Drugs / ACHN-789
last change Oct 2017 re-read 2 minutes ago

ACHN-789

Investigated by
Achaogen, Inc.

Trials 1 · a red edge is where a trial was stopped

201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT03163550 May → Oct 2017 Achaogen, Inc. Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as ACHN-789 ClinicalTrials.gov intervention name — accepted as the source's own label NCT03163550
Route Oral Oral dose” NCT03163550